Finance

Lists
Why is 006280 up 2,08%?
Dive Deeper
006280:KRX
GC Biopharma Corp
₩127 600,00
+2,08%
(+2 600,00) 1D
16 Okt., 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 006280...
Open
₩126 500
High
₩130 600
Low
₩125 500
Mkt. cap
1,49 bn
Avg. vol.
19,80 k
Volume
0,00
Dividend
1,18%
Quarterly dividend
â‚©375
Ex-dividend date
30 Mrt. 2026
52-wk high
₩183 800
52-wk low
₩105 900
EPS
-₩4 372
Shares outstanding
11,69 m
No. of employees
2 k
Open
₩126 500
High
₩130 600
Low
₩125 500
Mkt. cap
1,49 bn
Avg. vol.
19,80 k
Volume
0,00
Dividend
1,18%
Quarterly dividend
â‚©375
Ex-dividend date
30 Mrt. 2026
52-wk high
₩183 800
52-wk low
₩105 900
EPS
-₩4 372
Shares outstanding
11,69 m
No. of employees
2 k
News stories
From web sources and news partners
Profile
GC Biopharma also known as Green Cross Corporation is a biopharmaceutical company headquartered in Yongin, South Korea. Wikipedia
About GC Biopharma Corp
CEOEun Chul Huh | Il-sup Huh
Employees2,11 k
Founded05 Okt. 1967
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
609,49 mjd
497,75 mjd
435,53 mjd
421,18 mjd
Cost of goods sold
463,97 mjd
357,85 mjd
313,13 mjd
312,00 mjd
Cost of revenue
463,97 mjd
357,85 mjd
313,13 mjd
312,00 mjd
Research and development expenses
33,48 mjd
44,81 mjd
35,32 mjd
38,34 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
77,09 mjd
83,01 mjd
70,35 mjd
65,07 mjd
Operating expense
116,30 mjd
135,30 mjd
110,67 mjd
107,45 mjd
Total operating expenses
580,27 mjd
493,15 mjd
423,80 mjd
419,45 mjd
Operating income
29,21 mjd
4,60 mjd
11,73 mjd
1,73 mjd
Other non operating income
13,04 m
636,32 m
-10,15 mjd
-6,20 mjd
EBT including unusual items
24,89 mjd
-110,07 mjd
28,59 mjd
-1,60 mjd
EBT excluding unusual items
21,52 mjd
-4,39 mjd
25,91 mjd
-14,17 mjd
Income tax expense
6,74 mjd
-7,27 mjd
8,45 mjd
-2,65 mjd
Effective tax rate
27,07%
6,61%
29,56%
165,54%
Other operating expenses
296,00 m
306,00 m
590,00 m
308,00 m
Net income
15,95 mjd
-88,30 mjd
20,47 mjd
1,98 mjd
Net profit margin
2,62%
-17,74%
4,70%
0,47%
Earnings per share
1,40 k
-
1,79 k
174,00
Interest and investment income
605,00 m
623,00 m
881,00 m
418,00 m
Interest expense
-12,76 mjd
-13,40 mjd
-13,27 mjd
-11,50 mjd
Net interest expenses
-12,15 mjd
-12,77 mjd
-12,39 mjd
-11,08 mjd
Depreciation and amortization charges
1,68 mjd
2,17 mjd
1,63 mjd
1,22 mjd
EBITDA
50,70 mjd
24,79 mjd
34,46 mjd
22,90 mjd
Gain or loss from assets sale
-268,00 m
1,01 mjd
-35,56 mjd
38,60 m
AI content may include mistakes. Learn more
Google-programme